Quince Therapeutics
$32.50
64
+$1.19+3.8% Thursday 20:00
+$0.00+0%Thursday 22:33After hours
Statistics
Day High
32.5
Day Low
32.5
52W High
910
52W Low
15.1
Volume
1,185
Avg. Volume
-
Mkt Cap
33.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-28.02
6.52
41.06
75.6
Expected EPS
-4.0325
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-83.98MNet Income
Analyst Ratings
52.00Average Price Target
The highest estimate is 82.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow QNCX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.75B
Editas Medicine
EDIT
Mkt Cap477.63M
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Voyager Therapeutics
VYGR
Mkt Cap208.88M
Protagonist Therapeutics
PTGX
Mkt Cap9.99B
Fate Therapeutics
FATE
Mkt Cap279.18M
Regenxbio
RGNX
Mkt Cap707.66M
About
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Show more...
CEO
Dirk Thye
Employees
38
Country
United States
ISIN
US22053A3059
Listings
0 Comments
Share your thoughts
FAQ
What is Quince Therapeutics stock price today?▼
The current price of QNCX is $32.50 USD — it has increased by +3.8% in the past 24 hours. Watch Quince Therapeutics stock price performance more closely on the chart.
What is Quince Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Quince Therapeutics stocks are traded under the ticker QNCX.
Is Quince Therapeutics stock price growing?▼
QNCX stock has fallen by -4.21% compared to the previous week, the month change is a +67.79% rise, over the last year Quince Therapeutics has showed a -89.45% decrease.
What is Quince Therapeutics market cap?▼
Today Quince Therapeutics has the market capitalization of 33.05M
When is the next Quince Therapeutics earnings date?▼
Quince Therapeutics is going to release the next earnings report on November 18, 2026.
What were Quince Therapeutics earnings last quarter?▼
QNCX earnings for the last quarter are -12.31 USD per share, whereas the estimation was -28.02 USD resulting in a +56.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quince Therapeutics revenue for the last year?▼
Quince Therapeutics revenue for the last year amounts to 0 USD.
What is Quince Therapeutics net income for the last year?▼
QNCX net income for the last year is -83.98M USD.
How many employees does Quince Therapeutics have?▼
As of August 28, 2026, the company has 38 employees.
In which sector is Quince Therapeutics located?▼
Quince Therapeutics operates in the Health & Wellness sector.
When did Quince Therapeutics complete a stock split?▼
The last stock split for Quince Therapeutics was on June 30, 2026 with a ratio of 1:20.
Where is Quince Therapeutics headquartered?▼
Quince Therapeutics is headquartered in SOUTH SAN FRANCISCO, United States.